Global Anticoagulants Market Size, Share, Growth Analysis, By Drug class(Vitamin K Antagonists (VKAs) and Direct Oral Anticoagulants (DOACs)), By Distribution channel(Hospital Pharmacies, Retail Pharmacies) - Industry Forecast 2023-2030

Global Anticoagulants Market size was valued at USD 28.50 Billion in 2022 and is expected to grow from USD 31.44 Billion in 2023 to reach USD 68.87 Billion by 2031, at a CAGR of 10.30% during the forecast period (2024-2031).

The global anticoagulants market has experienced substantial growth recently, propelled by the increasing prevalence of chronic diseases and the adoption of unhealthy lifestyles contributing to a rise in cardiovascular diseases. This has led to a heightened demand for anticoagulants in the market. According to the World Health Organization (WHO) and the Cureus Journal of Medical Science, cardiovascular diseases rank among the leading causes of global mortality, accounting for around 17.9 million deaths annually, representing 35% of total global deaths. Within these fatalities, 85% are linked to heart attacks and strokes. Ischemic heart disease (IHD) has emerged as a significant contributor to worldwide mortality, affecting approximately 126 million individuals globally, representing about 1.72% of the global population. Projections suggest that the prevalence of IHD is anticipated to exceed 1,845 per 100,000 individuals by the year 2030. Anticoagulants play a crucial role in preventing blood clotting, thereby reducing the risk of heart attacks, strokes, and other cardiovascular complications. Alongside traditional anticoagulant therapies, novel oral anticoagulants (NOACs) have gained prominence. These newer drugs offer advantages such as improved safety profiles, simplified dosing regimens, and fewer drug interactions compared to traditional anticoagulants like warfarin. The increasing adoption of NOACs by healthcare professionals and patients has further propelled the growth of the global anticoagulants market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Anticoagulants Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Anticoagulants Market Segmental Analysis

Global Anticoagulants Market is segmented by drug class, distribution channel, and region. Based on drug class, the market can be segmented into vitamin k antagonists (vkas), and direct oral anticoagulants (doacs). Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Anticoagulants Market

One key driver of the global anticoagulants market is the increasing prevalence of cardiovascular diseases, including ischemic heart disease (IHD), worldwide. With millions of deaths each year attributed to cardiovascular diseases, there is a growing need for effective treatments to prevent heart attacks and strokes. This rising disease burden has resulted in a higher demand for anticoagulant medications, driving the growth of the market. Additionally, the adoption of novel oral anticoagulants (NOACs) has further fueled the market expansion, offering improved safety and convenience compared to traditional anticoagulants.

Restraints in the Global Anticoagulants Market

A notable constraint for the global anticoagulants market is the potential for bleeding complications linked to anticoagulant therapy. Although these medications play a crucial role in preventing blood clots, they also elevate the risk of bleeding events, which, in certain instances, can be life-threatening. Balancing the benefits of anticoagulant therapy against the potential adverse effects poses a challenge for healthcare professionals. Moreover, the high cost associated with anticoagulant medications can impede their accessibility, particularly in developing regions, further constraining the growth of the market.

Market Trends of the Global Anticoagulants Market

A notable trend in the global anticoagulants market is the growing preference for direct oral anticoagulants (DOACs) over traditional anticoagulant therapies like warfarin. DOACs present benefits such as predictable dosing, fewer drug interactions, and reduced necessity for frequent monitoring, enhancing patient adherence. The shift towards DOACs is propelled by their convenience and improved safety profiles. Furthermore, ongoing research and development endeavors aim to broaden the scope of indications for DOACs, contributing to their increasing popularity in the market.